TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Bergentoft Pharma Consulting AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
185
|
115
|
61 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
114
|
79
|
36 |
EBITDA |
114
|
79
|
36 |
Total assets |
264
|
166
|
104 |
Current assets |
174
|
166
|
104 |
Current liabilities |
69
|
40
|
21 |
Equity capital |
181
|
118
|
75 |
- share capital |
4
|
5
![]() |
5 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
68.6%
|
71.1%
|
72.1% |
Turnover per employee |
185
|
115
|
61 |
Profit as a percentage of turnover |
61.6%
|
68.7%
|
59.0% |
Return on assets (ROA) |
43.2%
|
47.6%
|
34.6% |
Current ratio |
252.2%
|
415.0%
|
495.2% |
Return on equity (ROE) |
63.0%
|
66.9%
|
48.0% |
Change turnover |
79
|
55
|
-36 |
Change turnover % |
75%
|
91%
|
-37% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.